JPS5936700A - Plasmid - Google Patents

Plasmid

Info

Publication number
JPS5936700A
JPS5936700A JP57147035A JP14703582A JPS5936700A JP S5936700 A JPS5936700 A JP S5936700A JP 57147035 A JP57147035 A JP 57147035A JP 14703582 A JP14703582 A JP 14703582A JP S5936700 A JPS5936700 A JP S5936700A
Authority
JP
Japan
Prior art keywords
fragments
plasmid
molecular weight
halophilic bacterium
halobacterium halobium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57147035A
Other languages
Japanese (ja)
Other versions
JPH0634724B2 (en
Inventor
Akihiko Kikuchi
菊池 韶彦
Keiko Asai
敬子 浅井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kasei Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Priority to JP57147035A priority Critical patent/JPH0634724B2/en
Publication of JPS5936700A publication Critical patent/JPS5936700A/en
Publication of JPH0634724B2 publication Critical patent/JPH0634724B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)

Abstract

PURPOSE:Plasmid expected to be useful as a vector for preparing an active component of isoprenoid derivative, carotenoid derivative, etc., obtained from highly halophilic bacterium of Halobacterium halobium. CONSTITUTION:Cyclic plasmid having 27 megadalton molecular weight, obtained by subjecting a mold of variant derived from a highly halophilic bacterium of Halobacterium halobium R1(FERM-P 6677) to bacteriolysis in a low hypotonic solution, treating it with an alkali to give a plasmid fragment, removing protein from it with phenol, purifying it, which is decomposed with restriced enzyme BamHI into 6 fragments, with Hind III into 2 fragments, with BalI into 6 fragments, with PvuII into 7 fragments, with KpnI into 4 fragments, with HpaI into 2 fragments, and with SatI into 8 fragments, respectively. The plasmid has 61 GC(%) base composition and 92.5 deg.C melting temperature(Tm).

Description

【発明の詳細な説明】 本発明はプラスミドに関する。詳しくは高度好塩菌ハロ
バクテリウムハロビウムから得られる新規なプラスミド
に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to plasmids. Specifically, the present invention relates to a novel plasmid obtained from the highly halophilic bacterium Halobacterium halobium.

染色体外遺伝子であるグラスミドは、インビトロ(in
 vizro) 遺伝子組換えにおけるベクター (v
ector)  として、遺伝子工学において広く広い
Grasmid, an extrachromosomal gene, has been developed in vitro.
vizro) vector in genetic recombination (v
ector) is widely used in genetic engineering.

本発明者等は、高い塩濃度がデオキシリボ核酸(DNA
)の高次41t令に及ぼす影響を検討するため、高度好
塙市のプラスミドを検索中のところ、ハロバクテリウム
ハロビウムから新しいグラスミドを分離することに成功
し1本発明を達成した。すなわち1本発明の要旨は、高
度好塊菌ハロバクテリウムハロビウムから得られ。
The present inventors have demonstrated that high salt concentrations cause deoxyribonucleic acid (DNA
), we were searching for plasmids from Halobacterium halobium in order to investigate the effect on higher-order 41t instars, and we succeeded in isolating a new glasmid from Halobacterium halobium, thus achieving the present invention. That is, one gist of the present invention is obtained from the highly agglomerative bacterium Halobacterium halobium.

制限r!#累に対し下記の分解特性を有する分子量、2
2メガダルトンの環状プラスミド Ba綬H1でご個の断片に%H1nd量でコ個の断片に
、 Ba11でに個の断片に、 pvu Hで7個の断
片(r(、Kpn lでグ個の断片に* Hpa 1で
2個の断片に、8θtlで?個の断片にそれぞれ分解さ
れる。
Limit r! #Molecular weight with the following decomposition characteristics for cumulative, 2
The 2-megadalton circular plasmid Ba-H1 was used to generate 1 fragments, Ba11 was used to generate 2 fragments, and pvu H was used to generate 7 fragments (r(, Kpnl). * It is decomposed into two fragments at Hpa 1 and into ? fragments at 8θtl.

に存する。exists in

本発明の詳細な説明するに1本発明における供試閘は、
高度好塩菌〕10バクテリウムノ−ロビラム(Halo
bacterium halobium ) R,由来
の変異株である。ハロバクブリラムノ10ビウムR0は
株(微工研菌寄第乙乙77号)である。
To explain in detail the present invention, the test lock in the present invention is as follows:
Highly halophilic bacteria] 10 Bacterium norobilum (Halo
It is a mutant strain derived from Bacterium halobium) R. Harobakuburi Rhamno 10 Bium R0 is a strain (Feikoken Bacteria No. 77).

この菌は所謂古細菌(アルケバクチリア)に属し、古細
菌のなかで唯一のプラスミドを有し、通常的、2j%濃
度の食塩の存在下においてのみ生育し、かつ細胞内は低
#度であるため細胞膜を挾んでNa  イオンを積極的
に排除する機構をもっている。視紅素(ロドプシン)と
類似するバクテリオロドプシンを有し、光の刺激に対し
て電子を動かす仕組みをもっている。さらにアルギニン
を唯一のエネルギー源として嫌気的にATPを生産する
ことができ、またその構成成分としてイソプレノイドの
誘導体、カロチノイドの誘導体などの有用成分が見出さ
れている。
This bacterium belongs to the so-called archaebacteria (Archebacteria), has the only plasmid among archaea, normally grows only in the presence of 2j% concentration of salt, and has a low concentration of salt inside the cell. Therefore, it has a mechanism to sandwich the cell membrane and actively exclude Na ions. It has bacteriorhodopsin, which is similar to rhodopsin, and has a mechanism that moves electrons in response to light stimulation. Furthermore, ATP can be produced anaerobically using arginine as the only energy source, and useful components such as isoprenoid derivatives and carotenoid derivatives have been discovered as its constituent components.

本発明のプラスミドは、上述の710バクテリウムハロ
ビウムR1は株の菌体な、後記実施例に具体的に記述す
る方法に従って、低張液で溶菌し、アシカリ処理して得
られるグラスミド分画を7エノールで除蛋白し、精製す
ることによって分離することができる。
The plasmid of the present invention is a glasmid fraction obtained by lysing the bacteria of the above-mentioned 710 Bacterium halobium R1 strain with a hypotonic solution and treating with Ashikari according to the method specifically described in the Examples below. It can be separated by deproteinizing with 7 enol and purifying it.

本発明のプラスミドの分子量は、アガロースゲル電気泳
動および透過型電子顕微鏡写真による測定の結果から、
、27メガダル・トン(、yz、sキロベース)である
。また塩基組成はaC(勉=乙/であり%融解温度(’
I1m)はタコ、5°0である。
The molecular weight of the plasmid of the present invention can be determined from the results of measurements using agarose gel electrophoresis and transmission electron microscopy.
, 27 megadal tons (,yz,s kilobases). In addition, the base composition is aC (Tsu = Otsu/) and the % melting temperature ('
I1m) is an octopus, 5°0.

さらに1本発明のプラスミドの制限酵素による分解断片
の分子量はつぎの通りである。
Furthermore, the molecular weight of the restriction enzyme digested fragment of the plasmid of the present invention is as follows.

分子量(単位はメガダシトン) BamH7:  ’?0.3,3.9..f、3..2
.9j、、2.り、2゜7H1ni Ill  : 、
22,91. i、IBad工 : /、J’(,12
勾、 !、/ 、 、2.7 、.2.Z 、 /、3
Pvu [1: //、2.3.9. 、?、0..2
,7..2.u、 2−、 /、VKpn l  : 
 //j、 10,1.3肥、7.2Hpa l  :
 /、?、?、 /3.θSsz  l  : 9.と
、1.0.2,2.♂、 2j 、 /、7 、 /、
! 、 /、j 、 0゜7以上に述べたように、本発
明のプラスミドは。
Molecular weight (unit: megadacyton) BamH7: '? 0.3, 3.9. .. f, 3. .. 2
.. 9j,,2. ri, 2゜7H1ni Ill: ,
22,91. i, IBad Engineering: /, J'(,12
Gag, ! , / , , 2.7 , . 2. Z, /, 3
Pvu [1: //, 2.3.9. ,? ,0. .. 2
,7. .. 2. u, 2-, /, VKpn l:
//j, 10,1.3 fertilizer, 7.2Hpa l:
/,? ,? , /3. θSsz l: 9. and 1.0.2,2. ♂、2j、/、7、/、
! , /, j , 0°7 As stated above, the plasmid of the present invention.

い。さらに、前記の好塩菌)\ロバクテリウムノ13− ロビウムR1株の諸性状に徴し、本発明のプラスミドは
、例えば、イソプレノイド誘導体、カロチノイド誘導体
などの有用成分の産生用ベクターとしての用途が期待さ
れる。
stomach. Furthermore, due to the properties of the above-mentioned halophilic bacterium Robacterium no. 13- Robium R1 strain, the plasmid of the present invention is expected to be used as a vector for producing useful components such as isoprenoid derivatives and carotenoid derivatives.

以下本発明を実施例につい【説明する。The present invention will be described below with reference to Examples.

実施例 (1)  菌の培養 ハロバクテリウムハロビウムR1は■を下記組成の寒天
培地上に接種し、37℃で約ダ日間装置培養する。
Example (1) Cultivation of Bacteria Halobacterium halobium R1 (2) was inoculated onto an agar medium having the following composition and cultured in an apparatus at 37°C for about 1 day.

寒天培地/lの組成 (pH4,j) イーストエキス       rg バタトトリプトン      !9 Na(12,1011 Mg80.・ りH,O、tli Oa O1t           (7、−y寒天 
   /jll 得られたコcr=−を下記組成の液体培地(本培養の7
770倍り  中に植菌し、37℃で約3日間振とう培
養し、前培養を行う。
Composition of agar medium/l (pH 4, j) Yeast extract rg Batatotryptone! 9 Na (12,1011 Mg80.・ riH, O, tli Oa O1t (7, -y agar
/jll The obtained coco cr=- was transferred to a liquid medium with the following composition (main culture 7
Inoculate the cells into a 770-fold culture medium and culture with shaking at 37°C for about 3 days to perform preculture.

 4− これを1本培養の液体培地に植え継ぎ、3り°0で約7
日間振とう培養を行う。
4- Subplant this into a single culture liquid medium and grow it for about 7 hours at 3°C.
Perform shaking culture for 1 day.

液体培地/lの組成(pHt、J ) カザミノ酸          7.j 5フイースト
エキス        1017NaO1コtoy Mg80.・7H,0209 /−の/;t、9t%F6804@りH* O(W、/
’V )(2)  プラスミドの調製 (1)で得られた培養液から遠心で菌体を集める。これ
を、下記組成の抗菌用緩衝液にサスペンドし、7000
rpm、10分間遠心して。
Composition of liquid medium/l (pHt, J) Casamino acids 7. j 5 yeast extract 1017NaO1 toy Mg80.・7H,0209 /-'s/;t, 9t%F6804@riH*O(W,/
'V) (2) Preparation of plasmid Collect bacterial cells from the culture solution obtained in (1) by centrifugation. This was suspended in an antibacterial buffer solution with the following composition, and
rpm, centrifuge for 10 minutes.

上清をすてる。Discard the supernatant.

抗菌用緩衝液100−の組成(pH4j)Mail  
        、2 ! 1Mg80.・7H,0,
2F クエン酸ナトリウム   0.3g XCZ           θ−y このようにして得られた菌体を溶液1〔夕θmM f 
k コ−ス、70mM  0yDTA (シクロヘキサ
ンジアミン四酢酸)、J−tmn  トリス塩酸pHざ
、0〕/−にサスペンドし、さらに同溶液9 mgを加
え均一にとかす。次に、溶液■[0゜、2M MaOH
,7%(W/V) B D 8 (ドデシル硫酸ナトリ
ウム))、2(7−を加え、0℃で70分間静かに攪拌
する。さらに溶液1[jMCHaO’JOK11.2M
 CHaCOOH] / j meを加え、O゛0で2
0分間放置し、変性タンパク、8D13変性DNA等?
沈殿させる。これを/200θrpmで75分間遠心し
、上清をとり、Q、ご倍量のイソグロパノールを加えて
、攪拌してのち、−コθ℃で一晩放置する。
Composition of antibacterial buffer 100- (pH 4j) Mail
, 2! 1Mg80.・7H, 0,
2F Sodium citrate 0.3g
K course, 70mM 0yDTA (cyclohexanediaminetetraacetic acid), J-tmn Tris-HCl pH 0]/-, and then add 9 mg of the same solution and dissolve uniformly. Next, add solution ■ [0°, 2M MaOH
, 7% (W/V) B D 8 (sodium dodecyl sulfate)), 2 (7-) and stirred gently at 0°C for 70 minutes.
CHaCOOH] / j Add me, O゛0 to 2
Leave for 0 minutes to remove denatured protein, 8D13 denatured DNA, etc.
Precipitate. This was centrifuged at /200 θ rpm for 75 minutes, the supernatant was taken, and twice the amount of isoglopanol was added, stirred, and left overnight at -θ°C.

次いで1.5′0θOrpm、/θ分間遠心し、上清を
捨て沈殿物を30mM  トリス塩酸(pシ、0)−o
、/ M OH,00ONa緩衝液にとかし1等量の水
飽和フェノールを加え1手で振とうして遠心により、水
層な集める。
Then, centrifugation was performed for 1.5'0θOrpm, /θ minutes, the supernatant was discarded, and the precipitate was diluted with 30mM Tris-HCl (psi, 0)-o.
, /M OH,00ONa buffer, add 1 equivalent of water-saturated phenol, shake with one hand, and collect the aqueous layer by centrifugation.

さらに、クロロホルム−イソアミルアルコール(,2グ
: / v/v )を等量加え、振と覆し。
Furthermore, an equal amount of chloroform-isoamyl alcohol (2 g/v/v) was added, and the mixture was shaken and inverted.

これを遠心して水層を集め、再度クロロホルム−イソア
ミルアルコールを加えて除蛋白を行う。
This is centrifuged to collect the aqueous layer, and chloroform-isoamyl alcohol is added again to remove protein.

このようにして得られた水層に5.2倍量のエタノール
を加えて攪拌して一一θ℃で2〜3時間放償する。次い
で、 jOθOrpm / 0分間の遠心でDNAを沈
殿させ、jOmM  ト+)ス塩酸−2j mM Na
j]l!1DTA緩衝液(pHr、0)に溶解して、再
びコ倍量のエタノールで沈殿させてOH,0OONaを
除去し、アルコールをできるだけ除いてから、10m1
のjomM)リス塩酸−,2j mM Na!1EDT
A緩衝液に溶解し、さらに同緩衝液で、溶液lコ、9に
調整する。
5.2 times the amount of ethanol is added to the aqueous layer thus obtained, stirred and left at 11.theta.C for 2 to 3 hours. The DNA was then precipitated by centrifugation for 0 min/0 min and treated with 20 mM Na
j]l! Dissolve in 1DTA buffer (pHr, 0), precipitate again with double the amount of ethanol to remove OH,0OONa, remove as much alcohol as possible, and then add 10ml of
jomM) Lis-HCl-, 2j mM Na! 1EDT
Dissolve in buffer A and adjust the solution to 9 with the same buffer.

次に、73,217のセシウムクロライドを加え。Next, add 73,217 cesium chloride.

!■/ rnlHρエチジウムプロマイトコ。グーを加
えて静かに混合する。これを、ポリアロマ−チューブに
いれ、アルミキャップをつけた後、上部の穴から、流動
パラフィンを重層し。
! ■/ rnlHρ ethidium promitoko. Add the goo and mix gently. After putting this into a polyaromer tube and attaching an aluminum cap, liquid paraffin was layered through the hole at the top.

3JOOOrpmでグθ〜erH間、/!℃で遠  − 心を行う。3JOOOrpm between gθ and erH, /! Far in °C - Do your heart.

U、Vランプをあてると、2本のシャープなバンドが見
えるので下の方のバンドを集め。
When you shine the U and V lamps on it, you will see two sharp bands, so collect the bottom one.

セシウムクロライド−エチジウムブロマイドの溶液(、
tOmM)リス塩酸(pHr、0 ) −2/mM N
a11!1DTA J’、01/ 、  セシクムク。
Cesium chloride-ethidium bromide solution (,
tOmM) Lis-HCl (pHr, 0) -2/mM N
a11!1DTA J', 01/, Seshikumuku.

ライドrJ77、/、2!vrg/l、lH,O工’f
ジウムプCIYイド/、4 d )を加えて、再fj(
3j、000rpm4tQ〜グr時間、i、t℃で遠心
する。UVランプをあてると、バンドが1本観察される
ので、これを取り出し、n−ブタノールでダル!回抽出
してエチジウムブロマイドを除き。
Ride rJ77, /, 2! vrg/l, lH, O engineering'f
Add jimp CIYid/, 4d) and re-fj(
Centrifuge at 3j, 000 rpm 4tQ~gr hours, i, t°C. When you shine a UV lamp on it, you will see one band, so take it out and add n-butanol to it! Extract twice to remove ethidium bromide.

透析チューブにいれて10mM トリス塩酸(pHJ’
、θ) −/ mM Na、F!DTA緩衝液に対し。
Add 10mM Tris-HCl (pHJ') to a dialysis tube.
, θ) −/mM Na,F! against DTA buffer.

数時間以上g ℃で透析する。得られたグラスミドは、
7℃で保存する。
Dialyze at g °C for several hours or more. The obtained glasmid is
Store at 7°C.

(3)  分子量の測定 (21で得られたグラスミドをアガロースゲル電気泳動
及び電子顕微鏡写真により1分子量を測定した結果1分
子量は、27メガダルト 8− ンであることが判明した。使用したアガロースゲル電気
泳動及びDNAの検出条件は、下記の通りである。
(3) Measurement of molecular weight (The molecular weight of Grasmid obtained in step 21 was measured by agarose gel electrophoresis and electron microscopy, and the molecular weight was found to be 27 megadaltons.The agarose gel electrophoresis used The conditions for electrophoresis and DNA detection are as follows.

電気泳動装置:サブマリン型電気泳動装置(/7X/j
crn)を使用した。
Electrophoresis device: Submarine type electrophoresis device (/7X/j
crn) was used.

電気泳動:0.09M)リス、θ、θりMホク酸、 J
、j mM Na、EDTAを含む緩衝液に7%(W/
りのアガロースを溶解させて、その上にDNAすyプル
を置いて、100V、j〜4を時間泳動を行う。
Electrophoresis: 0.09M) Lis, θ, θri M Hocic acid, J
, j mM Na, 7% (W/
Dissolve the remaining agarose, place the DNA sample on top of it, and perform electrophoresis at 100V for 4 hours.

泳動後、ゲルを00−2μg/−のエチジウムブロマイ
ド溶液にひたして染色し、TJV、2/4tnm照射下
で、ポラロイドフィルムで撮影する。
After electrophoresis, the gel is stained by soaking it in 00-2 μg/− of ethidium bromide solution and photographed with Polaroid film under TJV, 2/4 tnm irradiation.

(4)制限酵素による分解 (2)で得られたグラスミドを表/の各種制限酵素と共
に表7の緩衝液中で37℃、7時間反応させる。反応溶
液にr OmM Wag E!DTA 。
(4) React the grasmid obtained in step (2) with restriction enzymes in the buffer shown in Table 7 at 37°C for 7 hours with the various restriction enzymes shown in Table. Add r OmM Wag E! to the reaction solution. D.T.A.

!%5DS1.26%グリセリフ、0.0jt%(W/
Y )ブロムフェノールブルーの混合溶液な//j倍量
加え反応を停止させ、アガロースゲル電気泳動法により
、DNA断片の分子量を測定した。インターナルマーカ
ーとしては。
! %5DS1.26% Glycerif, 0.0jt% (W/
Y) A mixed solution of bromophenol blue in an amount of //j times was added to stop the reaction, and the molecular weight of the DNA fragment was measured by agarose gel electrophoresis. As an internal marker.

λDNAをHlnd lおよびBamH7で分解したD
NA断片を、またcoIE / (プラスミド)をHa
e lで分解したものを使用した。
λDNA was digested with Hlndl and BamH7
NA fragment and coIE/(plasmid) to Ha
The one decomposed by el was used.

各種制限酵素で分解して得られた断片の分子量を表2に
示す。
Table 2 shows the molecular weights of fragments obtained by digestion with various restriction enzymes.

表 / 出願人 三菱化成工業株式会社 手続ネ市正書(自発) 特許庁長官 若 杉 和 夫 殿 1 事件の表示   昭和57年特許願第147035
号2 発明の名称   プラスミド 3 補正をする者 事件との関係  出願人 (596)  三菱化成工業株式会社 4代理人 東京都千代田区丸の内二丁目5番2号 (ばか 1名) 5 補正の対象 明細書の「発明の詳細な説明」の欄 6 補正の内容 (1)明細書第11頁の表1の下から2行にrHpn 
 IJとあるのをrHpa  IJと訂正する。
Table / Applicant Mitsubishi Chemical Industries, Ltd. Procedural Official Report (spontaneous) Commissioner of the Patent Office Kazuo Wakasugi 1 Case Description Patent Application No. 147035, filed in 1982
No. 2 Name of the invention Plasmid 3 Relationship with the person making the amendment Applicant (596) Mitsubishi Chemical Industries, Ltd. 4 Agents 2-5-2 Marunouchi, Chiyoda-ku, Tokyo (1 idiot) 5 Specification subject to amendment Column 6 of “Detailed Description of the Invention” Contents of amendment (1) rHpn in the second row from the bottom of Table 1 on page 11 of the specification
IJ is corrected to rHpa IJ.

(2)明am第12頁の族2中、5行に「PVa  …
」とあるのを!fvul[Jと訂正する。
(2) On page 12 of Akira Am, in group 2, line 5 says “PVa...
” it says! Correct as fvul[J.

以上that's all

Claims (1)

【特許請求の範囲】[Claims] (1)  高置好塩菌ハロバクテリウムノ10ビウムか
ら得られ、制限酵素に対し下記の分解特性を有する、分
子量27メガダルトンの環状グラスミド。 BamHIでに個の断片に、Bindl  で−個の断
片に、 Bal lで6個の断片に、 Pvu lで7
個の断片にh Kpn Iでグ個の断片に* apa 
Iで2個の断片に、 sat 1でr個の断片にそれぞ
れ分解される。
(1) A cyclic grasmid with a molecular weight of 27 megadaltons, which is obtained from the halophilic bacterium Halobacterium novum and has the following decomposition characteristics with respect to restriction enzymes. BamHI to 2 fragments, Bindl to - 2 fragments, Bal to 6 fragments, Pvul to 7 fragments.
kpn I to 5 fragments* apa
It is decomposed into 2 fragments by I, and into r fragments by sat 1.
JP57147035A 1982-08-25 1982-08-25 Plasmid Expired - Lifetime JPH0634724B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57147035A JPH0634724B2 (en) 1982-08-25 1982-08-25 Plasmid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57147035A JPH0634724B2 (en) 1982-08-25 1982-08-25 Plasmid

Publications (2)

Publication Number Publication Date
JPS5936700A true JPS5936700A (en) 1984-02-28
JPH0634724B2 JPH0634724B2 (en) 1994-05-11

Family

ID=15421048

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57147035A Expired - Lifetime JPH0634724B2 (en) 1982-08-25 1982-08-25 Plasmid

Country Status (1)

Country Link
JP (1) JPH0634724B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6010885A (en) * 1993-03-25 2000-01-04 The Regents Of The University Of California Expression of heterologous polypeptides in halobacteria

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BIOORGANICHESKAYA KHIMIYA=1982 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6010885A (en) * 1993-03-25 2000-01-04 The Regents Of The University Of California Expression of heterologous polypeptides in halobacteria

Also Published As

Publication number Publication date
JPH0634724B2 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
RU2124053C1 (en) Method of preparing genetically modified bacteria sorangium/polyangium and recombinant plasmid dna molecule
AU611652B2 (en) Process for the genetic modification of monocotyledonous plants
EP0387527B1 (en) Process for the fermentative production of L-lysine
CN111793591B (en) Salmonella mutant strain capable of efficiently stimulating immune response and construction method and application thereof
JP7544351B2 (en) A novel strain of Pseudozyma antarctica
US20220118075A1 (en) Hansenula engineering fungi efficiently expressing ca10 virus-like particles and use thereof
CN113683667B (en) Engineering bacterium obtained by modification of YH66-RS10865 gene and application thereof in valine preparation
JPS6185192A (en) Conversion of characteristic of cephalosporium cell
CN106554971A (en) The preparation method of the transgenic rye grass of expressing gene recombination human serum albumin
FR2559781A1 (en) NOVEL HYBRID PLASMIDIC VECTOR OF E. COLI PROVIDING THE POWER TO FERMENT SUCROSE AND ITS PREPARATION METHOD
JPS5936700A (en) Plasmid
WO2021062886A1 (en) Preparation and transformation methods for bacillus subtilis competent cell
US6821752B2 (en) Methods and compositions for extracting proteins from cells
JPS62503074A (en) Methods for stabilizing unstable genetic replicons
JPS62155081A (en) Novel microorganism and production of biotin by fermentation with said microorganism
CN114540393A (en) Porcine circovirus type 3 virus-like particle and construction method and application thereof
CN113563436A (en) Engineering bacterium obtained by YH66-RS03880 gene transformation and application thereof in preparation of valine
CN108203697B (en) Yeast engineering bacterium of fish natural killer cell enhancement factor and application thereof
CN112279899A (en) Method for purifying prokaryotic expression protein
Cameron et al. The effects of Escherichia coli and yeast DNA insertions on the growth of lambda bacteriophage
EP3390638A1 (en) Meningococcal infection and modifiedneisseria lactamica
CN115976086B (en) Method for editing bacteria CRISPR-Cas9 gene and application thereof
CN117256728B (en) Attapulgite surfactant, and preparation and application thereof
CN113493745B (en) Genetically engineered bacterium for producing cephalosporin C and construction method thereof
CN115896151B (en) Construction method and application of food-grade recombinant duck tembusu virus truncated E gene lactococcus lactis vector